PRIMARY SCLEROSING CHOLANGITIS IN ULCERATIVE-COLITIS - A RISK FACTOR FOR THE DEVELOPMENT OF DYSPLASIA AND DNA ANEUPLOIDY

被引:155
|
作者
BROOME, U
LINDBERG, G
LOFBERG, R
机构
[1] Unit of Gastroenterology, Department of Medicine, Karolinska Institute, Huddinge
关键词
D O I
10.1016/0016-5085(92)90308-L
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In a 15-year surveillance program for long-standing, total ulcerative colitis (UC), 72 patients were followed up with colonoscopic biopsies. Seventeen patients developed definite dysplasia, carcinoma, and/or DNA aneuploidy. Alkaline phosphatase and transaminases were examined in all patients. In the group with dysplasia, carcinoma, and/or DNA aneuploidy, 5 patients (28%) were found to have primary sclerosing cholangitis (PSC) based on histological and/or cholangiographic criteria. In the group without definite dysplasia or DNA aneuploidy, no patient with PSC appeared, although two patients with other forms of chronic liver disorders were found. The difference in distribution of PSC between the two groups was statistically significant (P = 0.0004). Using logistic regression, the presence of PSC and the duration of UC were identified as independent risk factors associated with dysplasia and/or DNA aneuploidy. Thus, UC patients with PSC seem to run an increased risk of developing colonic dysplasia and/or DNA aneuploidy. Although the reason for the increased risk is still unclear, these results warrant increased surveillance among patients with both PSC and longstanding, total UC. © 1992.
引用
收藏
页码:1877 / 1880
页数:4
相关论文
共 50 条
  • [11] HLA ANTIGENS IN ULCERATIVE-COLITIS AND PRIMARY SCLEROSING CHOLANGITIS
    LEIDENIUS, MHK
    KOSKIMIES, SA
    KELLOKUMPU, IH
    HOCKERSTEDT, KAV
    APMIS, 1995, 103 (7-8) : 519 - 524
  • [13] PREVALENCE OF PRIMARY SCLEROSING CHOLANGITIS IN PATIENTS WITH ULCERATIVE-COLITIS
    OLSSON, R
    DANIELSSON, A
    JARNEROT, G
    LINDSTROM, E
    LOOF, L
    ROLNY, P
    RYDEN, BO
    TYSK, C
    WALLERSTEDT, S
    GASTROENTEROLOGY, 1991, 100 (05) : 1319 - 1323
  • [14] SERUM AUTOANTIBODIES, ULCERATIVE-COLITIS AND PRIMARY SCLEROSING CHOLANGITIS
    CHAPMAN, RW
    COTTONE, M
    SELBY, WS
    SHEPHERD, HA
    SHERLOCK, S
    JEWELL, DP
    GUT, 1986, 27 (01) : 86 - 91
  • [15] THE NATURE OF ULCERATIVE-COLITIS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    GREENBLOOM, SL
    STEINHART, AH
    GASTROENTEROLOGY, 1994, 106 (04) : A692 - A692
  • [16] HLA PHENOTYPES IN PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE-COLITIS
    DONALDSON, PT
    WILKINSON, ML
    EDDLESTON, ALWF
    WILLIAMS, R
    GUT, 1986, 27 (05) : A615 - A615
  • [17] FAMILIAL OCCURRENCE OF PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE-COLITIS
    QUIGLEY, EMM
    LARUSSO, NF
    LUDWIG, J
    MACSWEEN, RNM
    BIRNIE, GG
    WATKINSON, G
    GASTROENTEROLOGY, 1983, 85 (05) : 1160 - 1165
  • [18] The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis
    Marchesa, P
    Lashner, BA
    Lavery, IC
    Milsom, J
    Hull, TL
    Strong, SA
    Church, JM
    Navarro, G
    Fazio, VW
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1997, 92 (08): : 1285 - 1288
  • [19] SCLEROSING CHOLANGITIS, ULCERATIVE-COLITIS AND MYXEDEMA
    TOUQUET, VLR
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1984, 77 (01) : 84 - 85
  • [20] COLORECTAL NEOPLASIA IN PATIENTS WITH ULCERATIVE-COLITIS AND PRIMARY SCLEROSING CHOLANGITIS
    GURBUZ, AK
    GIARDIELLO, FM
    BAYLESS, TM
    DISEASES OF THE COLON & RECTUM, 1995, 38 (01) : 37 - 41